Text and Data Mining valid from 2019-11-26
Received: 12 August 2019
Accepted: 6 November 2019
First Online: 26 November 2019
: All animal studies were approved by the University of Texas MD Anderson Cancer Center IACUC under protocol 00001378-RN01.
: Not Applicable.
: MC is a consultant for Merck, Inc. and the Founder and Chairman of the Board of Immunogenesis, Inc. The remaining authors declare no potential conflicts of interest.